Page last updated: 2024-11-01

nifedipine and Hypoparathyroidism

nifedipine has been researched along with Hypoparathyroidism in 2 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Hypoparathyroidism: A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goswami, G1
Gurtoo, A1
Mayan, H1
Hourvitz, A1
Schiff, E1
Farfel, Z1

Other Studies

2 other studies available for nifedipine and Hypoparathyroidism

ArticleYear
Hypertension and hypoparathyroidism--narrowed therapeutic safety with nifedipine.
    Postgraduate medical journal, 1993, Volume: 69, Issue:815

    Topics: Adult; Contraindications; Female; Humans; Hypertension; Hypocalcemia; Hypoparathyroidism; Hypotensio

1993
Symptomatic hypocalcaemia in hypermagnesaemia-induced hypoparathyroidism, during magnesium tocolytic therapy--possible involvement of the calcium-sensing receptor.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:7

    Topics: Adult; Calcium; Female; Humans; Hypocalcemia; Hypoparathyroidism; Indomethacin; Magnesium; Nifedipin

1999